Cargando…
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes
OBJECTIVE: We examined the association of urine complement proteins with progression to end-stage renal disease (ESRD) or death in people with type 2 diabetes and proteinuric diabetic kidney disease (DKD). RESEARCH DESIGN AND METHODS: Using targeted mass spectrometry, we quantified urinary abundance...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196831/ https://www.ncbi.nlm.nih.gov/pubmed/30150236 http://dx.doi.org/10.2337/dc18-0699 |
_version_ | 1783364630685417472 |
---|---|
author | Vaisar, Tomas Durbin-Johnson, Blythe Whitlock, Kathryn Babenko, Ilona Mehrotra, Rajnish Rocke, David M. Afkarian, Maryam |
author_facet | Vaisar, Tomas Durbin-Johnson, Blythe Whitlock, Kathryn Babenko, Ilona Mehrotra, Rajnish Rocke, David M. Afkarian, Maryam |
author_sort | Vaisar, Tomas |
collection | PubMed |
description | OBJECTIVE: We examined the association of urine complement proteins with progression to end-stage renal disease (ESRD) or death in people with type 2 diabetes and proteinuric diabetic kidney disease (DKD). RESEARCH DESIGN AND METHODS: Using targeted mass spectrometry, we quantified urinary abundance of 12 complement proteins in a predominantly Mexican American cohort with type 2 diabetes and proteinuric DKD (n = 141). The association of urine complement proteins with progression to ESRD or death was evaluated using time-to-event analyses. RESULTS: At baseline, median estimated glomerular filtration rate (eGFR) was 54 mL/min/1.73 m(2) and urine protein-to-creatinine ratio 2.6 g/g. Sixty-seven participants developed ESRD or died, of whom 39 progressed to ESRD over a median of 3.1 years and 40 died over a median 3.6 years. Higher urine CD59, an inhibitor of terminal complement complex formation, was associated with a lower risk of ESRD (hazard ratio [HR] [95% CI per doubling] 0.50 [0.29–0.87]) and death (HR [95% CI] 0.56 [0.34–0.93]), after adjustment for demographic and clinical covariates, including baseline eGFR and proteinuria. Higher urine complement components 4 and 8 were associated with lower risk of death (HR [95% CI] 0.57 [0.41–0.79] and 0.66 [0.44–0.97], respectively); higher urine factor H–related protein 2, a positive regulator of the alternative complement pathway, was associated with greater risk of death (HR [95% CI] 1.61 [1.05–2.48]) in fully adjusted models. CONCLUSIONS: In a largely Mexican American cohort with type 2 diabetes and proteinuric DKD, urine abundance of several complement and complement regulatory proteins was strongly associated with progression to ESRD and death. |
format | Online Article Text |
id | pubmed-6196831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-61968312019-11-01 Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes Vaisar, Tomas Durbin-Johnson, Blythe Whitlock, Kathryn Babenko, Ilona Mehrotra, Rajnish Rocke, David M. Afkarian, Maryam Diabetes Care Pathophysiology/Complications OBJECTIVE: We examined the association of urine complement proteins with progression to end-stage renal disease (ESRD) or death in people with type 2 diabetes and proteinuric diabetic kidney disease (DKD). RESEARCH DESIGN AND METHODS: Using targeted mass spectrometry, we quantified urinary abundance of 12 complement proteins in a predominantly Mexican American cohort with type 2 diabetes and proteinuric DKD (n = 141). The association of urine complement proteins with progression to ESRD or death was evaluated using time-to-event analyses. RESULTS: At baseline, median estimated glomerular filtration rate (eGFR) was 54 mL/min/1.73 m(2) and urine protein-to-creatinine ratio 2.6 g/g. Sixty-seven participants developed ESRD or died, of whom 39 progressed to ESRD over a median of 3.1 years and 40 died over a median 3.6 years. Higher urine CD59, an inhibitor of terminal complement complex formation, was associated with a lower risk of ESRD (hazard ratio [HR] [95% CI per doubling] 0.50 [0.29–0.87]) and death (HR [95% CI] 0.56 [0.34–0.93]), after adjustment for demographic and clinical covariates, including baseline eGFR and proteinuria. Higher urine complement components 4 and 8 were associated with lower risk of death (HR [95% CI] 0.57 [0.41–0.79] and 0.66 [0.44–0.97], respectively); higher urine factor H–related protein 2, a positive regulator of the alternative complement pathway, was associated with greater risk of death (HR [95% CI] 1.61 [1.05–2.48]) in fully adjusted models. CONCLUSIONS: In a largely Mexican American cohort with type 2 diabetes and proteinuric DKD, urine abundance of several complement and complement regulatory proteins was strongly associated with progression to ESRD and death. American Diabetes Association 2018-11 2018-08-27 /pmc/articles/PMC6196831/ /pubmed/30150236 http://dx.doi.org/10.2337/dc18-0699 Text en © 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
spellingShingle | Pathophysiology/Complications Vaisar, Tomas Durbin-Johnson, Blythe Whitlock, Kathryn Babenko, Ilona Mehrotra, Rajnish Rocke, David M. Afkarian, Maryam Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes |
title | Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes |
title_full | Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes |
title_fullStr | Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes |
title_full_unstemmed | Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes |
title_short | Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes |
title_sort | urine complement proteins and the risk of kidney disease progression and mortality in type 2 diabetes |
topic | Pathophysiology/Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196831/ https://www.ncbi.nlm.nih.gov/pubmed/30150236 http://dx.doi.org/10.2337/dc18-0699 |
work_keys_str_mv | AT vaisartomas urinecomplementproteinsandtheriskofkidneydiseaseprogressionandmortalityintype2diabetes AT durbinjohnsonblythe urinecomplementproteinsandtheriskofkidneydiseaseprogressionandmortalityintype2diabetes AT whitlockkathryn urinecomplementproteinsandtheriskofkidneydiseaseprogressionandmortalityintype2diabetes AT babenkoilona urinecomplementproteinsandtheriskofkidneydiseaseprogressionandmortalityintype2diabetes AT mehrotrarajnish urinecomplementproteinsandtheriskofkidneydiseaseprogressionandmortalityintype2diabetes AT rockedavidm urinecomplementproteinsandtheriskofkidneydiseaseprogressionandmortalityintype2diabetes AT afkarianmaryam urinecomplementproteinsandtheriskofkidneydiseaseprogressionandmortalityintype2diabetes |